Results 141 to 150 of about 37,478 (219)

Establishment and validation of a risk scoring model for predicting the risk of bladder stones in patients with benign prostatic hyperplasia. [PDF]

Front Med (Lausanne)
Luo Y, Gao Y, Fang H, Shi C, Xu J, Li X, Li Y.   +6 more
europepmc   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Characterizing the academic literature on surgical management of benign prostatic hyperplasia: A bibliometric analysis. [PDF]

World J Urol
Tozsin A, Arslan E, Ermiş O, Akgül B, Güven S, Herrmann TR.   +5 more
europepmc   +1 more source

Benign prostatic hyperplasia to HPIN to carcinoma; the impact of mast cells and VEGF. [PDF]

Diagn Pathol
Sivrikoz ON, Eroğlu A, Öztürk B, Öztop İ, Sanal SM.   +4 more
europepmc   +1 more source

Feasibility of multifrequency MR elastography of the seminal vesicles in healthy men, benign prostatic hyperplasia, and prostate cancer. [PDF]

Eur Radiol Exp
Davis KV, Thiess HM, Asbach P, Tiberi E, Denecke T, Hamm B, Gebauer B, Vogel-Claussen J, Sack I, Reiter R.   +9 more
europepmc   +1 more source

Modified water vapor thermal therapy for large-volume benign prostatic hyperplasia. [PDF]

BMC Urol
Lu Q, Zhu G, Liu J, Huang H, Zhang F, Qiu X, Xu L, Guo H.   +7 more
europepmc   +1 more source

Airborne chloride exposure and benign prostatic hyperplasia risk. [PDF]

BMC Res Notes
Shi J, Phanumartwiwath A.
europepmc   +1 more source

Imaging of benign prostatic hyperplasia

Seminars in Roentgenology, 1999
openaire   +2 more sources

5 Alpha Reductase Inhibitors (5ARIs) Monotherapy and Combinations: Current Role in Benign Prostatic Hyperplasia (BPH) Management. [PDF]

Medicina (Kaunas)
Roidos C, Sountoulides P, Papathanasiou K, Symeonidis A, Mykoniatis I.   +4 more
europepmc   +1 more source

Causal links of 233 metabolic markers to benign prostatic hyperplasia: Mendelian randomization and RNA-sequencing insights. [PDF]

J Chin Med Assoc
Zhou P, Zhu Z.
europepmc   +1 more source